Osteoporosis
Osteoporosis
Osteoporosis
Disediakan oleh :
Aini Izzati Abd Gaffar
112015443
What is osteoporosis?
Osteoporosis : porous bone
Definition
Abnormally low bone mass
Defects in bone structure
Unusually fragile
Greater than normal risk of fracture in a person of that
age, sex and race
WHO
HOW??
Predominant bone resorption
Decreased bone formation
Or a combination of the two
Alterations in bone formation and remodelling imbalance
between bone resorption and bone formation
Estrogen deficiency In the absence of estrogen, T cells promote
osteoclast recruitment, differentiation, and prolonged survival via
IL-1, IL-6, and tumor necrosis factor (TNF)alpha.
Ageing progressive decline in the supply of osteoblasts in
proportion to the demand.
Calcium deficiency Insufficient dietary calcium or impaired
intestinal absorption of calcium due to aging or disease can lead
to secondary hyperparathyroidism
Vitamin D deficiency result in secondary hyperparathyroidism
via decreased intestinal calcium absorption
WHERE??
Particularly, diaphyseo-metaphyseal junctions (in tubular
bones) and mainly cancellous vertebral bodies
Eventually reaches state in which a comparatively
modest stress or strain causes a fracture
Clinical features and diagnosis
Early stages without symptoms until fracture occurs
Loss of height over time (as much as 6 inches)
Stooped posture/kyphosis/ Dowagers hump may develop
Pain
Back pain
Increased thoracic kyphosis
Diminished height
X-ray
may be indicated if a
fracture is already
suspected or if patients
have lost more than 1.5
inches of height
Wedging or
compressions of one or
more vertebral bodies
Lateral view : * Sometimes, the first clinical event is a low energy
calcification of aorta fracture of distal radius ( Colles fracture), hip or ankle
(often)
Characteristics signs of severe postmenopausal
osteoporosis :
o compression fractures of vertebral bodies
o wedging at multiple levels
o biconcave distortion of vertebral end-plates
- due to bulging of intact intervertebral discs
Clinical and radiographic diagnosis should be backed up
by assessment of BMD
- As measured by DXA of spine and hips
- Indicative osteoporosis :
Normal women over 50 years, -2.5sd
DIAGNOSTIC APPROACH
Bone mass density (BMD) measurement
Indications:
Concerned perimenopausal woman willing to start drug therapy
Radiographic evidence of bone loss
Patient on long-term glucocorticoid therapy (more than one month of
therapy at a dosage of 7.5 mg [or higher] of prednisone per day)
Asymptomatic hyperparathyroidism where osteoporosis would suggest
parathyroidectomy
Monitoring therapeutic response in women undergoing treatment for
osteoporosis if the result of the test would affect the clinical decision
DXA
(Dual energy x ray Absorptiometry)
Show significantly reduced bone density
in vertebral bodies or femoral neck
Postmenopausal osteoporosis
symptomatic postmenopausal osteoporosis : exaggerated
form of physiologic bone depletion
- Normally accompanies ageing and loss of gonadal
activity
2 overlapping phases :
1. High turnover osteoporosis
- Early postmenopausal syndrome : rapid bone loss
( predominantly increased osteoclastic resorption)
2. Low turnover osteoporosis
- Emerges in elderly
- Due to gradual slow-down in osteoblastic activity
- Increasing effects of dietary insufficiencies
- Chronic ill-health
- Reduced mobility
Bone loss accelerates to about 3% per year around
menopause and the next 10 years
Compared to 0.3% during preceding two decades
Mainly due to :
- Increased bone resorption
- Withdrawal oestrogen (restraints on osteoclastic activity)
- Genetic influences
- Risk factors
Prevention and treatment
Prophylactic treatment :
- Women at more than usual risk of suffering fracture at
menopause (bone densitometry)
- DXA screening :
o usually reserved for women with multiple risk factors
o Particularly those with suspected oestrogen deficiency
(premature or surgically induced menopause)
o Bone losing disorder
o One who already suffered previous low-energy fractures
at menopause
Maintain adequate levels of dietary calcium and vitamin D
Keep up high level of physical activity
Avoid smoking
Avoid excessive consumption alcohol
If necessary, calcium and vit D supplements (to met
recommended daily requirements)
Hormone replacement therapy (HRT)
Was the most widely used medication for
postmenopausal osteoporosis
Oestrogen / combination oestrogen and progesterone (
for 5-10years)
Convincingly reduce risk of osteoporotic fractures
BUT
After stopping HRT, BMD gradually falls to usual low level
Apparent increase risks of thromboembolism, stroke,
breast cancer, uterine cancer
Biphosphonates
Now regarded as preferred medications
Mechanism of action:
- Reducing osteoclastic bone resorption , general rate of
bone turnover
Prevent bone loss + reduce risk of vertebral and hip
fractures
Alendronate : peroral, once-weekly doses for both
prevention and treatment ( GI side effects)
Pamidronate : IV, 3 months intervals
Parathyroid hormones